{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:50:35Z","timestamp":1793994635678,"version":"4.8.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T00:00:00Z","timestamp":1601251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T00:00:00Z","timestamp":1601251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cutaneous T-cell lymphomas (CTCL) are a heterogeneous group of extranodal non-Hodgkin lymphomas for which diagnosis can be challenging given the potential for overlap with inflammatory dermatoses. Current diagnostic criteria for CTCL incorporate clinical and histopathologic findings as well as results of T-cell receptor (TCR) gene sequencing. Molecular interrogation of TCR genes, <jats:italic>TRG<\/jats:italic> and <jats:italic>TRB<\/jats:italic>, has proven\u00a0to be a critical tool for confirming diagnoses of CTCL and for disease tracking after initiation of therapy or after stem cell transplant. Methods for confirming a diagnosis of lymphoma in the absence of TCR gene clonality are lacking. We present two patients with CTCL with pathogenic somatic mutations in the absence of <jats:italic>TRG<\/jats:italic> and <jats:italic>TRB<\/jats:italic> clonality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentations<\/jats:title>\n                <jats:p>Case 1: A 38-year-old male had a 19-year history of a diffuse skin rash with papulosquamous, granulomatous, and verrucous features and progressive ulcerated plaques and tumors demonstrating an atypical CD4+ T-cell infiltrate with expression of cytotoxic markers CD56, TIA-1, granzyme, and perforin on histopathology. No definitive evidence for T-cell clonality was detected by conventional PCR of 6 biopsies or by next-generation sequencing (NGS) of 14 biopsies. Somatic mutational profiling of a skin biopsy revealed pathogenic mutations in <jats:italic>PIKC3D<\/jats:italic> and <jats:italic>TERT<\/jats:italic> promoter hotspots, confirming the presence of a clonal process. Case 2: A 69-year-old male with a 13-year history of progressive, diffuse hypertrophic and eroded plaques showed an atypical CD4+ T-cell infiltrate with subset expression of TIA-1 and granzyme on histopathology. No TCR clonality was detected by TCR-NGS of 6 biopsies. Somatic mutational profiling of a skin biopsy detected a pathogenic mutation in <jats:italic>TP53<\/jats:italic>, confirming the presence of a clonal process.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These cases highlight how detection of pathogenic somatic mutations can confirm\u00a0a diagnosis of lymphoma in a clinically and histopathologically suspicious cutaneous lymphoid proliferation without detectable TCR clonality.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13000-020-01022-x","type":"journal-article","created":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T15:03:47Z","timestamp":1601305427000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Cutaneous T-cell lymphomas with pathogenic somatic mutations and absence of detectable clonal T-cell receptor gene rearrangement: two case reports"],"prefix":"10.1186","volume":"15","author":[{"given":"Rebecca","family":"Rojansky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Fernandez-Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerri E.","family":"Rieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto A.","family":"Novoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Zehnder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian A.","family":"Kunder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youn H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Khodadoust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9099-7227","authenticated-orcid":false,"given":"Ryanne A.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,28]]},"reference":[{"issue":"16","key":"1022_CR1","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","volume":"133","author":"R Willemze","year":"2019","unstructured":"Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019;133(16):1703\u201314.","journal-title":"Blood."},{"issue":"1\u20132","key":"1022_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0009-8981(91)90247-A","volume":"198","author":"JJ van Dongen","year":"1991","unstructured":"van Dongen JJ, Wolvers-Tettero IL. Analysis of immunoglobulin and T cell receptor genes. Part II: possibilities and limitations in the diagnosis and management of lymphoproliferative diseases and related disorders. Clin Chim Acta. 1991;198(1\u20132):93\u2013174.","journal-title":"Clin Chim Acta"},{"issue":"5","key":"1022_CR3","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/00000372-199910000-00019","volume":"21","author":"R Bergman","year":"1999","unstructured":"Bergman R. How useful are T-cell receptor gene rearrangement studies as an adjunct to the histopathologic diagnosis of mycosis fungoides? Am J Dermatopathol. 1999;21(5):498\u2013502.","journal-title":"Am J Dermatopathol"},{"issue":"8","key":"1022_CR4","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1034\/j.1600-0560.2002.290801.x","volume":"29","author":"N Holm","year":"2002","unstructured":"Holm N, Flaig MJ, Yazdi AS, Sander CA. The value of molecular analysis by PCR in the diagnosis of cutaneous lymphocytic infiltrates. J Cutan Pathol. 2002;29(8):447\u201352.","journal-title":"J Cutan Pathol"},{"issue":"3","key":"1022_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/jclinpath-2017-204761","volume":"71","author":"E Mahe","year":"2018","unstructured":"Mahe E, Pugh T, Kamel-Reid S. T cell clonality assessment: past, present and future. J Clin Pathol. 2018;71(3):195\u2013200.","journal-title":"J Clin Pathol"},{"issue":"1","key":"1022_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/path.1711620102","volume":"162","author":"D Slater","year":"1990","unstructured":"Slater D. Clonal dermatoses: a conceptual and diagnostic dilemma. J Pathol. 1990;162(1):1\u20133.","journal-title":"J Pathol"},{"issue":"3","key":"1022_CR7","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1001\/archderm.1989.01670150092016","volume":"125","author":"V Mielke","year":"1989","unstructured":"Mielke V, Wolff HH, Winzer M, Sterry W. Localized and disseminated pagetoid reticulosis. Diagnostic immunophenotypical findings. Arch Dermatol. 1989;125(3):402.","journal-title":"Arch Dermatol."},{"issue":"5","key":"1022_CR8","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jaad.2007.06.004","volume":"57","author":"SE Thurber","year":"2007","unstructured":"Thurber SE, Zhang B, Kim YH, Schrijver I, Zehnder J, Kohler S. T-cell clonality analysis in biopsy specimens from two different skin sites shows high specificity in the diagnosis of patients with suggested mycosis fungoides. J Am Acad Dermatol. 2007;57(5):782\u201390.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1022_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/biom9040153","volume":"9","author":"A Papa","year":"2019","unstructured":"Papa A, Pandolfi PP. The PTEN\u2013PI3K Axis in Cancer. Biomolecules. 2019;9(4):153.","journal-title":"Biomolecules."},{"issue":"1","key":"1022_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jaci.2014.02.020","volume":"134","author":"S Kracker","year":"2014","unstructured":"Kracker S, Curtis J, Ibrahim MAA, Sediva A, Salisbury J, Campr V, et al. Occurrence of B-cell lymphomas in patients with activated Phosphoinositide 3-kinase \u03b4 syndrome. J Allergy Clin Immunol. 2014;134(1):233\u20136.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"1022_CR11","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.jaci.2019.03.017","volume":"143","author":"CJ Nunes-Santos","year":"2019","unstructured":"Nunes-Santos CJ, Uzel G, Rosenzweig SD. PI3K pathway defects leading to immunodeficiency and immune dysregulation. J Allergy Clin Immunol. 2019;143(5):1676\u201387.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1022_CR12","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","volume":"139","author":"TI Coulter","year":"2017","unstructured":"Coulter TI, Chandra A, Bacon CM, Babar J, Curtis J, Screaton N, et al. Clinical spectrum and features of activated phosphoinositide 3-kinase \u03b4 syndrome: A large patient cohort study. J Allergy Clin Immunol. 2017;139(2):597\u2013606 e4.","journal-title":"J Allergy Clin Immunol."},{"issue":"4","key":"1022_CR13","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1158\/2159-8290.CD-16-0330","volume":"7","author":"M McKinney","year":"2017","unstructured":"McKinney M, Moffitt AB, Gaulard P, Travert M, De Leval L, Nicolae A, et al. The genetic basis of hepatosplenic T-cell lymphoma. Cancer Discov. 2017;7(4):369\u201379.","journal-title":"Cancer Discov"},{"key":"1022_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/science.1229259","volume-title":"Highly Recurrent TERT Promoter Mutations in Human Melanoma","author":"FW Huang","year":"2013","unstructured":"Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA. Highly Recurrent TERT Promoter Mutations in Human Melanoma; 2013."},{"issue":"1","key":"1022_CR15","doi-asserted-by":"publisher","first-page":"20302","DOI":"10.1038\/s41598-019-56891-0","volume":"9","author":"JY Hong","year":"2019","unstructured":"Hong JY, Yoon DH, Yoon SE, Kim SJ, Lee HS, Eom HS, et al. Pralatrexate in patients with recurrent or refractory peripheral T-cell lymphomas: a multicenter retrospective analysis. Sci Rep. 2019;9(1):20302.","journal-title":"Sci Rep"},{"key":"1022_CR16","unstructured":"National Comprehensive Cancer Network. Non-Hodgkin's Lymphomas (Version 3.2016). https:\/\/jnccn.org\/view\/journals\/jnccn\/14\/9\/article-p1067.xml. ."},{"issue":"5","key":"1022_CR17","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.jmb.2011.12.001","volume":"415","author":"H Kim","year":"2012","unstructured":"Kim H, Kim K, Choi J, Heo K, Baek HJ, Roeder RG, et al. p53 requires an intact C-terminal domain for DNA binding and transactivation. J Mol Biol. 2012;415(5):843\u201354.","journal-title":"J Mol Biol"},{"issue":"21","key":"1022_CR18","doi-asserted-by":"publisher","first-page":"8536","DOI":"10.1073\/pnas.87.21.8536","volume":"87","author":"A Bourguin","year":"1990","unstructured":"Bourguin A, Tung R, Galili N, Sklar J. Rapid, nonradioactive detection of clonal T-cell receptor gene rearrangements in lymphoid neoplasms. Proc Natl Acad Sci U S A. 1990;87(21):8536\u201340.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1022_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1182\/blood-2014-07-588236","volume":"125","author":"CF Hughes","year":"2015","unstructured":"Hughes CF, Khot A, McCormack C, Lade S, Westerman DA, Twigger R, et al. Lack of durable disease control with chemotherapy for mycosis fungoides and S\u00e9zary syndrome: a comparative study of systemic therapy. Blood. 2015;125(1):71\u201381.","journal-title":"Blood."},{"issue":"7","key":"1022_CR20","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1182\/bloodadvances.2018027482","volume":"3","author":"A Iyer","year":"2019","unstructured":"Iyer A, Hennessey D, O'Keefe S, Patterson J, Wang W, Salopek T, et al. Clonotypic heterogeneity in cutaneous T-cell lymphoma (mycosis fungoides) revealed by comprehensive whole-exome sequencing. Blood Adv. 2019;3(7):1175\u201384.","journal-title":"Blood Adv"},{"issue":"18","key":"1022_CR21","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1182\/blood.2019002516","volume":"134","author":"A Iyer","year":"2019","unstructured":"Iyer A, Hennessey D, O'Keefe S, Patterson J, Wang W, Wong GK, et al. Skin colonization by circulating neoplastic clones in cutaneous T-cell lymphoma. Blood. 2019;134(18):1517\u201327.","journal-title":"Blood."},{"issue":"5","key":"1022_CR22","doi-asserted-by":"publisher","first-page":"8921","DOI":"10.18632\/oncotarget.13475","volume":"8","author":"K Hientz","year":"2017","unstructured":"Hientz K, Mohr A, Bhakta-Guha D, Efferth T. The role of p53 in cancer drug resistance and targeted chemotherapy. Oncotarget. 2017;8(5):8921\u201346.","journal-title":"Oncotarget."},{"issue":"1","key":"1022_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/CCO.0b013e3282f3111e","volume":"20","author":"S Wee","year":"2008","unstructured":"Wee S, Lengauer C, Wiederschain D. Class IA phosphoinositide 3-kinase isoforms and human tumorigenesis: implications for cancer drug discovery and development. Curr Opin Oncol. 2008;20(1):77\u201382.","journal-title":"Curr Opin Oncol"},{"issue":"3","key":"1022_CR24","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/bjd.12934","volume":"171","author":"F \u00c7etin\u00f6zman","year":"2014","unstructured":"\u00c7etin\u00f6zman F, Jansen PM, Willemze R. Expression of programmed death-1 in skin biopsies of benign inflammatory vs. lymphomatous erythroderma. Br J Dermatol. 2014;171(3):499\u2013504.","journal-title":"Br J Dermatol"},{"issue":"2","key":"1022_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/DAD.0000000000000258","volume":"37","author":"FM Bosisio","year":"2015","unstructured":"Bosisio FM, Cerroni L. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas. Am J Dermatopathol. 2015;37(2):115\u201321.","journal-title":"Am J Dermatopathol"},{"issue":"7","key":"1022_CR26","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1097\/01.pas.0000209855.28282.ce","volume":"30","author":"DM Dorfman","year":"2006","unstructured":"Dorfman DM, Brown JA, Shahsafaei A, Freeman GJ. Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma. Am J Surg Pathol. 2006;30(7):802\u201310.","journal-title":"Am J Surg Pathol"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-020-01022-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-020-01022-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-020-01022-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T23:15:31Z","timestamp":1632784531000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-020-01022-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,28]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1022"],"URL":"https:\/\/doi.org\/10.1186\/s13000-020-01022-x","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,28]]},"assertion":[{"value":"22 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was approved by the Institutional Review Board of Stanford University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient in Case 1 provided written informed consent for publication. The patient in Case 2 is deceased and informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"122"}}